HomePBYI • NASDAQ
add
Puma Biotechnology Inc
Previous close
$4.83
Day range
$4.72 - $5.06
Year range
$2.13 - $7.73
Market cap
235.25M USD
Avg Volume
470.62K
P/E ratio
10.75
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 72.18M | 9.90% |
Operating expense | 32.43M | -20.55% |
Net income | 12.27M | 318.84% |
Net profit margin | 17.00 | 299.06% |
Earnings per share | 0.31 | 542.86% |
EBITDA | 18.31M | 74.92% |
Effective tax rate | 4.19% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 95.94M | 18.34% |
Total assets | 230.53M | 3.81% |
Total liabilities | 177.09M | -11.66% |
Total equity | 53.44M | — |
Shares outstanding | 48.21M | — |
Price to book | 4.31 | — |
Return on assets | 17.76% | — |
Return on capital | 24.41% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 12.27M | 318.84% |
Cash from operations | 10.46M | 36.08% |
Cash from investing | -8.17M | 31.19% |
Cash from financing | — | — |
Net change in cash | 2.28M | 229.90% |
Free cash flow | 13.41M | 40.12% |
About
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA. Wikipedia
Founded
2007
Headquarters
Website
Employees
185